XML 82 R16.htm IDEA: XBRL DOCUMENT v3.2.0.727
Income Taxes
12 Months Ended
Jun. 30, 2015
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
The components of income (loss) from continuing operations before income taxes and income tax expense (benefit) were as follows:
 
Year Ended June 30,
 
2015
 
2014
 
2013
Income (loss) from continuing operations before income taxes:
 
 
 
 
 
United States
$
18,443

 
$
(6,068
)
 
$
(24,760
)
Foreign
352

 
155

 
477

 
$
18,795

 
$
(5,913
)
 
$
(24,283
)
Tax provision (benefit):
 
 
 
 
 
Federal:
 
 
 
 
 
Current
$
4,267

 
$
3,184

 
$
(699
)
Deferred
(458
)
 
(5,281
)
 
(9,613
)
 
$
3,809

 
$
(2,097
)
 
$
(10,312
)
State:
 
 
 
 
 
Current
$
1,372

 
$
594

 
$
157

Deferred
(921
)
 
(375
)
 
(710
)
 
$
451

 
$
219

 
$
(553
)
Foreign:
 
 
 
 
 
Current
$
58

 
$
(12
)
 
$
364

Deferred
48

 
49

 

 
$
106

 
$
37

 
$
364

 
$
4,366

 
$
(1,841
)
 
$
(10,501
)


The following is the reconciliation between the statutory federal income tax rate and the Company’s effective income tax (benefit) rate for continuing operations:
 
Year Ended June 30,
 
2015
 
2014
 
2013
Tax provision (benefit) at federal statutory rates
35.0
 %
 
(35.0
)%
 
(35.0
)%
State income tax, net of federal tax benefit
4.9

 
(3.1
)
 
(1.8
)
Research and development credits
(4.8
)
 
(14.7
)
 
(12.6
)
Domestic manufacturing deduction
(3.2
)
 
(5.3
)
 

Deemed repatriation of foreign earnings
(0.4
)
 
0.7

 

Foreign tax credits

 
(13.3
)
 

Equity compensation
(0.1
)
 
2.2

 
1.8

Officers' compensation
2.8

 
11.1

 

Stock compensation shortfalls

 
24.1

 

Deferred tax asset and liability adjustments
(4.2
)
 

 

Change in state tax rates
(3.1
)
 

 

Reserves for tax contingencies
(5.0
)
 

 

Acquisition costs

 

 
0.5

Valuation allowance

 

 
2.5

Other
1.3

 
2.2

 
1.4

 
23.2
 %
 
(31.1
)%
 
(43.2
)%


The components of the Company’s net deferred tax assets (liabilities) for continuing operations were as follows:
 
June 30,
 
2015
 
2014
Deferred tax assets:
 
 
 
Inventory valuation and receivable allowances
$
9,264

 
$
8,830

Accrued compensation
2,563

 
972

Equity compensation
4,229

 
4,831

Federal and state research and development tax credit carryforwards
16,262

 
11,167

Gain on sale-leaseback
834

 
1,232

Other accruals
1,889

 
1,043

Capital loss carryforwards
3,562

 

Other temporary differences
1,800

 
4,012

 
40,403

 
32,087

Valuation allowance
(18,864
)
 
(10,844
)
Total deferred tax assets
21,539

 
21,243

Deferred tax liabilities:
 
 
 
Prepaid expenses
(1,103
)
 

Property and equipment
(1,578
)
 
(1,694
)
Intangible assets
(7,110
)
 
(9,242
)
Tax method of accounting change
(854
)
 

Other temporary differences
(320
)
 
(624
)
Total deferred tax liabilities
(10,965
)
 
(11,560
)
Net deferred tax assets
$
10,574

 
$
9,683

 
 
 
 
As reported:
 
 
 
Current deferred tax assets
$
12,407

 
$
15,216

Non-current deferred tax assets (included in other non-current assets)
1,275

 
378

Non-current deferred tax liabilities
(3,108
)
 
(5,911
)
 
$
10,574

 
$
9,683


At June 30, 2015, the Company evaluated the need for a valuation allowance on deferred tax assets. In assessing whether the deferred tax assets are realizable, management considered whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the Company's past operating results, its forecast of future earnings, future taxable income, and tax planning strategies. The Company continues to conclude that it is more likely than not that most domestic deferred tax assets would be realizable based on the financial performance in fiscal year 2015, projected future taxable income and the reversal of existing deferred tax liabilities.
The Company continues to record a full valuation allowance on certain state research and development (“R&D”) and investment tax credits, and capital loss carryforwards as of June 30, 2015 as management continues to believe that it is not more likely than not that these deferred tax assets would be realized. Any future reversals of the valuation allowance will impact income tax expense.
The Company had federal research and development credit carryforwards of $959, which will expire from 2032 through 2033. The Company had state research and development credit carryforwards of $14,899, which will expire from 2016 through 2029. The Company also had state investment tax credits carryforwards of $404.
Upon consideration of changing business conditions and cash position in its foreign subsidiaries, management has determined that it does not need to indefinitely reinvest the earnings of certain foreign subsidiaries. Therefore, the Company has accrued deferred taxes in association with $672 in undistributed earnings and profits.
The Company files income tax returns in all jurisdictions in which it operates. The Company has established reserves to provide for additional income taxes that management believes will more likely than not be due in future years as these previously filed tax returns are audited. These reserves have been established based upon management’s assessment as to the potential exposures. All tax reserves are analyzed quarterly and adjustments are made as events occur and warrant modification.
The changes in the Company’s reserves for unrecognized income tax benefits are summarized as follows:
 
Year Ended June 30,
 
2015
 
2014
Unrecognized tax benefits, beginning of period
$
3,142

 
$
2,923

Increases for previously recognized positions
123

 
102

Reductions as a result of a lapse of the applicable statue of limitations
(1,197
)
 
(166
)
Increases for currently recognized positions
122

 
283

Unrecognized tax benefits, end of period
$
2,190

 
$
3,142


The $2,190 of unrecognized tax benefits as of June 30, 2015, if released, would reduce income tax expense.
The Company’s major tax jurisdiction is the U.S. and the open tax years are fiscal 2011 through 2015.
The Company is currently under audit by the Internal Revenue Service for fiscal year 2013. There have been no significant changes to the status of this examination during the year ended June 30, 2015. It is reasonably possible that within the next 12 months the Company’s unrecognized tax benefits, exclusive of interest, may decrease by up to $757 at the conclusion of the audit. We expect that the decrease, if recognized, would not affect the effective tax rate.